Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trialLetter Published on 2020-06-042022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 24 hour acute COVID-19 administration Anti-inflammatory ARDS block Blood blood cell Cell cells clinical Clinical improvement control group Cord blood COVID-19 COVID-19 patients dissemination dose Efficacy element Estimated feasibility feasible hospitalised patient immunomodulatory properties infected with SARS-CoV-2 injection intravenous Melbourne, Australia moderate New number objective occur outcome participant Patient Placebo Pneumonia Prevent progression protocol randomised randomised controlled trial RCT recruit recruitment Registered registry Safety Sample size SARS-COV-2 infection sealed severe ARDS severe pneumonia Standard status stem cells Study protocol supportive care therapy Tolerability Total Treatment Trial Umbilical cord umbilical cord blood virus website [DOI] 10.1186/s13063-020-04387-y PMC 바로가기 [Article Type] Letter
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 active malignancy acute respiratory distress syndrome Administered administration age approval approved ARDS assessment automated Berlin blinded Cell cell suspension cellular changes in chronic liver disease class clinical Clinical diagnosis Clinical outcome clinical outcomes clinical trial comparator Compliance conducted control group Controlled trial COVID 19 COVID-19 COVID-19 pandemic declined defined described determine diagnosis of COVID-19 dissemination Donor Dose escalation driving Effect Efficacy element eligible Elizabeth enrolled ethics committee EudraCT excluded facilitate failure fixed dose hospital ICU incidence Inclusion increase in index individual information infusion intensive care unit Intervention Invasive mechanical ventilation investigator King’s College London London Mesenchymal stem cells Mesenchymal stromal cells MHRA moderate Mortality MSC MSCs NIHR number objective open label Other outcome pandemic PaO participant Patient patient population patients with ARDS PCR test PF ratio Phase 1 Phase 2 Placebo placebo-controlled protocol protocol amendment Public randomised randomised controlled trial REC receiving recruited recruitment repair reported Research respiratory Resuscitation Sample size secondary Secondary objective Secondary outcomes Serious Adverse Events severe ARDS single intravenous infusion SOFA solution Standard steering committee stratified stromal cell Study protocol Therapeutics therapy trauma Treatment Trial triple blinded Trust umbilical United Kingdom university Venous Thromboembolism Ventilation verbal Volume web-based randomisation system website WHO Withdrawal [DOI] 10.1186/s13063-020-04416-w PMC 바로가기 [Article Type] Letter
A Case Report of Rapidly Lethal Acute Respiratory Distress Syndrome Secondary to Coronavirus Disease 2019 Viral PneumoniaInternal Medicine Published on 2020-05-212022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Acute kidney injury acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome age Berlin criteria Brain Case report cerebrovascular accident clinical status Comorbidities contribute coronavirus Coronavirus 2019 coronavirus disease (COVID-19) COVID-19 COVID-19 patients creatinine death dysfunction end-organ expired female highlight hospital hypertension hypoxic ICU intensive care Intubated lethal lethargic pandemic Patient positive Prognosis remained report respiratory Respiratory failure Respiratory function RNA sarcoidosis SARS-CoV-2 secondary to severe ARDS Swab test syndrome the patient type 2 diabete [DOI] 10.7759/cureus.8228 PMC 바로가기 [Article Type] Internal Medicine
COVID‐19 associated pulmonary aspergillosisOriginal Article Published on 2020-05-152022-10-30 Journal: Mycoses [Category] COVID-19, MERS, [키워드] acute respiratory distress ARDS Aspergillus Complication comprehensive analysis coronavirus disease COVID‐19 Critically ill patient detect ECMO evaluate FIVE Germany ICU intensive care invasive isavuconazole moderate objective Patient patients with ARDS respiratory sample Result retrospective risk SARS‐CoV‐2 severe ARDS subject surgical syndrome university viral infection voriconazole [DOI] 10.1111/myc.13096 PMC 바로가기 [Article Type] Original Article
COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative reviewReview Published on 2020-05-082022-11-01 Journal: Critical Care [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Characteristics Coagulation Complication coronavirus COVID-19 COVID-19 pandemic ECMO Efficacy Evidence extracorporeal membrane oxygenation global pandemic hematological Inflammatory initial symptoms management patients respiratory compromise Respiratory failure SARS-CoV-2 severe ARDS similarity therapy V-V ECMO while [DOI] 10.1186/s13054-020-02925-3 PMC 바로가기 [Article Type] Review